File(s) not publicly available
Cost-Utility and Cost-effectiveness of MoodSwings 2.0, an Internet-Based Self-management Program for Bipolar Disorder: Economic Evaluation Alongside a Randomized Controlled Trial
journal contribution
posted on 2023-02-16, 02:46 authored by ML Chatterton, Yong Yi Lee, Lesley BerkLesley Berk, Mohammadreza MohebbiMohammadreza Mohebbi, Michael BerkMichael Berk, T Suppes, S Lauder, Cathy MihalopoulosCathy MihalopoulosBackground: Internet-delivered psychosocial interventions can overcome barriers to face-to-face psychosocial care, but limited evidence supports their cost-effectiveness for people with bipolar disorders (BDs). Objective: This study aimed to conduct within-trial cost-effectiveness and cost-utility analyses of an internet-based intervention for people with BD, MoodSwings 2.0, from an Australian health sector perspective. Methods: MoodSwings 2.0 included an economic evaluation alongside an international, parallel, and individually stratified randomized controlled trial comparing an internet-based discussion forum (control; group 1), a discussion forum plus internet-based psychoeducation (group 2), and a discussion forum plus psychoeducation and cognitive behavioral tools (group 3). The trial enrolled adults (aged 21 to 65 years) with a diagnosis of BD assessed by telephone using a structured clinical interview. Health sector costs included intervention delivery and additional health care resources used by participants over the 12-month trial follow-up. Outcomes included depression symptoms measured by the Montgomery-Åsberg Depression Rating Scale (MADRS; the trial primary outcome) and quality-adjusted life years (QALYs) calculated using the short-form 6-dimension instrument derived from the 12-item version of the short-form health survey. Average incremental cost-effectiveness (cost per MADRS score) and cost-utility (cost per QALY) ratios were calculated using estimated mean differences between intervention and control groups from linear mixed effects models in the base case. Results: In total, 304 participants were randomized. Average health sector cost was lowest for group 2 (Aus $9431, SD Aus $8540; Aus $1=US $0.7058) compared with the control group (Aus $15,175, SD Aus $17,206) and group 3 (Aus $15,518, SD Aus $30,523), but none was statistically significantly different. The average QALYs were not significantly different among the groups (group 1: 0.627, SD 0.062; group 2: 0.618, SD 0.094; and group 3: 0.622, SD 0.087). The MADRS scores were previously shown to differ significantly between group 2 and the control group at all follow-up time points (P<.05). Group 2 was dominant (lower costs and greater effects) compared with the control group for average incremental cost per point decrease in MADRS score over 12 months (95% CI dominated to Aus $331). Average cost per point change in MADRS score for group 3 versus the control group was dominant (95% CI dominant to Aus $22,585). Group 2 was dominant (95% CI Aus $43,000 to dominant) over the control group based on lower average health sector cost and average QALY benefit of 0.012 (95% CI –0.009 to 0.033). Group 3, compared with the control group, had an average incremental cost-effectiveness ratio of dominant (95% CI dominated to Aus $19,978). Conclusions: Web-based psychoeducation through MoodSwings 2.0 has the potential to be a cost-effective intervention for people with BD. Additional research is needed to understand the lack of effectiveness for the addition of cognitive behavioral tools with the group 3 intervention.
History
Journal
JMIR Mental HealthVolume
9Article number
ARTN e36496Location
CanadaPublisher DOI
ISSN
2368-7959eISSN
2368-7959Language
EnglishIssue
11Publisher
JMIR PUBLICATIONS, INCUsage metrics
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicinePsychiatryeconomic evaluationcost-effectivenesscost-utilityclinical trialbipolar disorderpsychoeducationcognitive behavioral therapyinternet interventionmaniadepressionpsychiatryneurosciencemental disordersCOGNITIVE-BEHAVIORAL THERAPYUNSTRUCTURED GROUP SUPPORTMENTAL-HEALTHGROUP PSYCHOEDUCATIONANTIMANIC TREATMENTSONLINE INTERVENTIONMETAANALYSISDEPRESSIONEFFICACYILLNESSClinical Trials and Supportive ActivitiesDepressionCost Effectiveness ResearchBehavioral and Social ScienceHealth ServicesComparative Effectiveness ResearchBrain DisordersClinical ResearchMental HealthMental health3 Good Health and Well BeingPublic Health and Health Services not elsewhere classified
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC